Literature DB >> 19503707

Medicinal chemistry and therapeutic relevance of angiotensin-converting enzyme inhibitors.

Naser Z Alsharif1.   

Abstract

Chemical Basis of Drug Action (PHA337 and PHA447) is a required 2-semester course sequence taught to second-professional year pharmacy students at Creighton University in both the campus and distance-education pathways. The course emphasizes integration of previous content, critical thinking, and therapeutic relevance. The content and learning experiences are organized to transition the students' thinking through a constructive process that provides ample opportunities to recall and integrate previous knowledge, learn and apply new knowledge, establish a logical connection between the science and its therapeutic relevance, and finally to apply the science knowledge to predict clinical activity and clinical outcomes as can be expected in a patient. This manuscript is based on the angiotensin converting enzyme inhibitors as an illustration of how our course objectives are accomplished.

Entities:  

Keywords:  angiotensin converting enzyme inhibitors (ACEIs); medicinal chemistry; therapeutics, critical thinking

Mesh:

Substances:

Year:  2007        PMID: 19503707      PMCID: PMC2690933          DOI: 10.5688/aj7106123

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


  7 in total

1.  Instructional model to teach clinically relevant medicinal chemistry.

Authors:  Naser Z Alsharif; Kimberly A Galt; Ahmed Mehanna; Robert Chapman; Alaba M Ogunbadeniyi
Journal:  Am J Pharm Educ       Date:  2006-08-15       Impact factor: 2.047

2.  A quantitative assessment of a medicinal chemistry problem-based learning sequence.

Authors:  Andrew A Webster; Robert M Riggs
Journal:  Am J Pharm Educ       Date:  2006-08-15       Impact factor: 2.047

3.  Are all angiotensin-converting enzyme inhibitors interchangeable?

Authors:  C D Furberg; B Pitt
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

Review 4.  Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.

Authors:  R M Zusman
Journal:  Am J Kidney Dis       Date:  1987-07       Impact factor: 8.860

5.  Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure.

Authors:  D Ravid; M Lishner; R Lang; M Ravid
Journal:  J Clin Pharmacol       Date:  1994-11       Impact factor: 3.126

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 7.  Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics.

Authors:  G S Thind
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

  7 in total
  2 in total

1.  Design and implementation of a laboratory-based drug design and synthesis advanced pharmacy practice experience.

Authors:  Ashok Philip; Mark Stephens; Sheila L Mitchell; E Blake Watkins
Journal:  Am J Pharm Educ       Date:  2015-04-25       Impact factor: 2.047

2.  Laboratory exercises to teach clinically relevant chemistry of antibiotics.

Authors:  Khalid A El Sayed; Candace T Chelette
Journal:  Am J Pharm Educ       Date:  2014-03-12       Impact factor: 2.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.